Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

Abroad (travel likely)Recruiting

Conditions

Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Salvatore Cozzi, MD) · salvatore.cozzi@lyon.unicancer.fr
    Contact: Principal Investigator (Salvatore Cozzi, MD)
  • Institut de Cancérologie de Lorraine, Nancy, France

    Contact: Study coordinator (Marie Bruand, MD) · m.bruand@nancy.unicancer.fr
    Contact: Principal Investigator (Marie Bruand, MD)
  • Antoine Lacassagne Cancer Centre, Nice, France

    Contact: Study coordinator (Jean-Michel Hannoun-Levi, MD) · jean-michel.hannoun-levi@nice.unicancer.fr
    Contact: Principal Investigator (Jean-Michel Hannoun-Levi, MD)
  • Klinikum Bremerhaven, Bremerhaven, Germany

    Contact: Study coordinator (Razvan Galalae, MD) · Razvan.Galalae@klinikum-bremerhaven.de
    Contact: Principal Investigator (Razvan Galalae, MD)
  • University Hospital Erlangen, Erlangen, Germany

    Contact: Study coordinator (Vratislav Strnad, MD) · Vratislav.Strnad@uk-erlangen.de
    Contact: Principal Investigator (Vratislav Strnad, MD)
  • Universitätsklinikum Schleswig-Holstein, Lübeck, Germany

    Contact: Study coordinator (Tamer Soror, MD) · tamer.soror@uksh.de
    Contact: Principal Investigator (Tamer Soror, MD)
  • Sana Klinikum Offenbach, Offenbach, Germany

    Contact: Study coordinator (Peter Niehoff, MD) · Peter.Niehoff@Sana.de
    Contact: Principal Investigator (Peter Niehoff, MD)
  • Universitätsklinikum Würzburg, Würzburg, Germany

    Contact: Study coordinator (Büllent Polat, MD) · polat_b@ukw.de
    Contact: Principal Investigator (Büllent Polat, MD)
  • National Institute of Oncology, Budapest, Hungary

    Contact: Study coordinator (Smanykó Viktor, MD) · smanyko.viktor@oncol.hu · +3612248600
    Contact: Principal Investigator (Viktor Smanykó, MD)
  • National Cancer Institute, Vilnius, Lithuania

    Contact: Study coordinator (Justinas Jonusas, MD) · justinas.jonusas@nvi.lt
    Contact: Principal Investigator (Justinas Jonusas, MD)
  • Maria Skłodowska-Curie Bialystok Oncology Center, Bialystok, Poland

    Contact: Study coordinator (Dorota Kazberuk, MD) · d.kazberuk@onet.pl
    Contact: Principal Investigator (Dorota Kazberuk, MD)
  • Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny, Brzozów, Poland

    Contact: Study coordinator (Damian Kazalski, MD) · damian.kazalski@gmail.com
    Contact: Principal Investigator (Damian Kazalski, MD)
  • National Institute of Oncology, Gliwice, Poland

    Contact: Study coordinator (Magdalena Stankiewicz, MD) · Magdalena.Stankiewicz@io.gliwice.pl
    Contact: Principal Investigator (Magdalena Stankiewicz, MD)
  • Greater Poland Cancer Centre, Poznan, Poland

    Contact: Study coordinator (Adam Chicel, MD) · adam.chichel@wco.pl
    Contact: Principal Investigator (Adam Chicel, MD)
  • Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland

    Contact: Study coordinator (Katarzyna Konat-Bąska, MD) · Konatkasia@gmail.com
    Contact: Principal Investigator (Katarzyna Konat-Bąska, MD)
  • Instituto Português de Oncologia do Porto, Porto, Portugal

    Contact: Study coordinator (Pedro B Fenandes, MD) · pedro.fernandes@ipoporto.min-saude.pt
    Contact: Principal Investigator (Pedro B Fenandes, MD)
  • Oncology Institute Vojvodina, Kamenica, Serbia

    Contact: Study coordinator (Olivera Ivanov, MD) · olivera.ivanov@yahoo.com
    Contact: Principal Investigator (Olivera Ivanov, MD)
  • Fundacion IMOR's Oncology Clinic, Barcelona, Spain

    Contact: Study coordinator (Benjamin Guix, MD) · drguix@icloud.com
    Contact: Principal Investigator (Benjamin Guix, MD)
  • Institut Catala d'Oncologia, Barcelona, Spain

    Contact: Study coordinator (Cristina Gutierrez-Miguelez, MD) · cgutierrezm@iconcologia.net
    Contact: Principal Investigator (Cristina Gutierrez-Miguelez, MD)
  • Hospital Universitario de Navarra, Pamplona, Spain

    Contact: Study coordinator (Irene Martínez, MD) · mm.irene10@gmail.com
    Contact: Principal Investigator (Irene Martínez, MD)
  • Instituto Valenciano de Oncologia, Valencia, Spain

    Contact: Study coordinator (Jose-Luis Guinot, MD) · jguinot@fivo.org
    Contact: Principal Investigator (Jose-Luis Guinot, MD)
  • Inselspital, Universitätsspital Bern, Bern, Switzerland

    Contact: Study coordinator (Kristina Lössl, MD) · kristina.loessl@insel.ch
    Contact: Principal Investigator (Kristina Lössl, MD)
Study leads
  • Viktor Smanykó, MD

    Principal Investigator

    National Institute of Oncology, Budapest, Hungary